The following surgeons have joined ARC’s Clinical Advisory Board:
– Dr. Rudy De Wilde, PhD, ScD, MD. Dr. De Wilde is the Director of Ob/Gyn at Pius Hospital in Germany and a key opinion leader and principal investigator of adhesion clinical studies.
– Dr. Brian Kwon, MD, FRCSC, PhD. Dr. Kwon is a surgeon-scientist who is an Associate Professor in the Department of Orthopaedics (UBC), the Associate Director, Clinical Research, for ICORD and the Associate Scientific Director of the Rick Hansen Institute.
– Dr. Jian (James) Ye, MD, MSc, FRCSC. Dr. Ye is a cardiovascular surgeon, director of Clinical Research at St. Paul’s Hospital and a Clinical Professor of Surgery at UBC.
ARC successfully developed an animal spine (laminectomy) surgical adhesion model and showed compelling efficacy of fucoidan in preventing the formation of spinal adhesions in the spine model.
Fucoidan significantly reduced the formation of cardiac adhesions in an animal cardiac model.
ARC entered into an exclusive distribution and supply agreement with Vedco, Inc. for PERIDAN in the U.S. equine veterinary market.
ARC successfully developed an animal model for cardiac surgical adhesions.
Chris Springate was an invited speaker at Colorado State University College of Veterinary Medicine’s conference “Surgical Techniques & Management of the Acute Abdomen in the Horse” in April. Key equine surgeons from the U.S were there.
PERIDAN® equine veterinary product re-launched.
The U.S. FDA Center for Veterinary Medicine designated our veterinary product, PERIDAN®, as a veterinary medical device. Bioniche Life Sciences Inc., our veterinary partner, is ramping up production along with marketing and sales for the U.S. market.